Tanise R. Shattock, Ph.D. - Publications
Affiliations: | 2007 | University of South Florida, Tampa, FL, United States |
Area:
Pharmaceutical ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Lapidus SH, Stephens PW, Arora KK, Shattock TR, Zaworotko MJ. A comparison of cocrystal structure solutions from powder and single crystal techniques Crystal Growth and Design. 10: 4630-4637. DOI: 10.1021/Cg1009237 | 0.664 | |||
2009 | Weyna DR, Shattock T, Vishweshwar P, Zaworotko MJ. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: Mechanochemistry vs slow evaporation from solution Crystal Growth and Design. 9: 1106-1123. DOI: 10.1021/Cg800936D | 0.572 | |||
2008 | Lapidus S, Stephens P, Zaworotko M, Arora K, Shattock T. A comparison of co-crystal structure solutions through powder and single-crystal techniques Acta Crystallographica Section a Foundations of Crystallography. 64: C209-C209. DOI: 10.1107/S0108767308093306 | 0.707 | |||
2008 | Shattock TR, Arora KK, Vishweshwar P, Zaworotko MJ. Hierarchy of supramolecular synthons: Persistent carboxylic acid⋯pyridine hydrogen bonds in cocrystals that also contain a hydroxyl moiety Crystal Growth and Design. 8: 4533-4545. DOI: 10.1021/Cg800565A | 0.667 | |||
2005 | Vishweshwar P, McMahon JA, Peterson ML, Hickey MB, Shattock TR, Zaworotko MJ. Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients. Chemical Communications (Cambridge, England). 4601-3. PMID 16158128 DOI: 10.1039/B501304F | 0.725 | |||
2005 | McMahon JA, Bis JA, Vishweshwar P, Shattock TR, McLaughlin OL, Zaworotko MJ. Crystal engineering of the composition of pharmaceutical phases. 3 1. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals Zeitschrift Fur Kristallographie. 220: 340-350. DOI: 10.1524/Zkri.220.4.340.61624 | 0.579 | |||
2005 | Shattock TR, Vishweshwar P, Wang Z, Zaworotko MJ. 18-Fold interpenetration and concomitant polymorphism in the 2:3 co-crystal of trimesic acid and 1,2-bis(4-pyridyl)ethane Crystal Growth and Design. 5: 2046-2049. DOI: 10.1021/Cg0501985 | 0.667 | |||
Show low-probability matches. |